Best Practice & Research Clinical Anaesthesiology
Volume 24, Issue 1 , Pages 133-144 , March 2010

Hypercoagulability in the perioperative period

  • Vance G. Nielsen, MD, Professor, Director of Anesthesiology Research,

      Affiliations

    • Drexel University College of Medicine, Department of Anesthesiology, Philadelphia, Pennsylvania 19102, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Lars M. Asmis, MD, Head, Coagulation Laboratory,

      Affiliations

    • Department of Internal Medicine, Division of Hematology, University Hospital Zurich, Ramistrasse 100, CH-8091, Zurich, Switzerland

References 

  1. Schreiber MA, Differding J, Thorborg P, et al. Hypercoagulability is most prevalent early after injury and in female patients. The Journal of Trauma. 2005;58:475–480
  2. Datta I, Ball CG, Rudmik LR, et al. A multicenter review of deep venous thrombosis prophylaxis practice patterns for blunt hepatic trauma. Journal of Trauma Management & Outcomes. 2009;3:7
  3. Haut ER, Chang DC, Pierce CA, et al. Predictors of posttraumatic deep vein thrombosis (DVT): hospital practice versus patient factors – an analysis of the National Trauma Data Bank (NTDB). The Journal of Trauma. 2009;66:994–999
  4. Neumann CR, Brasil AV, Albers F. Risk factors for mortality in traumatic cervical spinal cord injury: Brazilian data. The Journal of Trauma. 2009;67:67–70
  5. Paffrath T, Wafaisade A, Lefering R, et al. Venous thromboembolism after severe trauma: incidence, risk factors and outcome. Injury,; PMID 19608183.
  6. Garcia-Avello A, Lorente JA, Cesar-Perez J, et al. Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thrombosis Research. 1998;89:59–64
  7. Wahl WL, Brandt MM, Ahrns K, et al. The utility of d-dimer levels in screening for thromboembolic complications in burn patients. The Journal of Burn Care & Rehabilitation. 2002;23:439–443
  8. Barret JP, Dziewulski PG. Compications of the hypercoagulable status in burn injury. Burns. 2006;32:1005–1008
  9. Faucher LD, Conlon KM. Practice guidelines for deep venous thrombosis prophylaxis in burns. Journal of Burn Care & Research. 2007;28:661–663
  10. Abraham P, Ternisien C, Hubert L, et al. Does venous microemboli detection add to the interpretation of d-dimer values following orthopedic surgery?. Ultrasound in Medicine & Biology. 1999;25:637–640
  11. Colwell CW. Rationale for thromboprohylaxis in lower joint arthroplasty. The American Journal of Orthopedics. 2007;36(9 Suppl):11–13
  12. Willis AA, Warren RF, Craig EV, et al. Deep vein thrombosis after reconstructive shoulder arthroplasty: a prospective observational study. Journal of Shoulder and Elbow Surgery. 2009;18:100–106
  13. Yoo MC, Cho YJ, Ghanem E, et al. Deep vein thrombosis after total hip arthroplasty in Korean patients and d-dimer as a screening tool. Archives of Orthopaedic and Trauma Surgery. 2009;129:887–894
  14. Ziegler S, Ortu A, Reale C, et al. Fibrinolysis or hypercoagulation during radical prostatectomy? An evaluation of thrombelastographic parameters and standard laboratory tests. European Journal of Anaesthesiology. 2008;25:538–543
  15. Einstein MH, Pritts EA, Hartenbach EM. Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review. Gynecol Oncol. 2007;105:813–819
  16. Ziegler S, Ortu A, Reale C, et al. Fibrinolysis or hypercoagulation during radical prostatectomy?An evaluation of thrombelastographic parameters and standard laboratory tests. Eur J Anaesthesiol. 2008;25:538–543
  17. Akl EA, Terrenato I, Barba M, et al. Extended perioperative thromboprophylaxis in patients with cancer. A systematic review. Thrombosis and Haemostasis. 2008;100:1176–1180
  18. Akay OM, Ustuner Z, Canturk Z, et al. Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography. Medical Oncology. 2009;26:358–364
  19. Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. Journal of Clinical Oncology. 2009;27:4834–4838
  20. Steenwyk BL, Kirklin JK, Gurley WQ, Nielsen VG. Hemostatic history of a 15 month old child implanted with a Berlin left ventricular assist device prior to transplantation. Anesthesia and Analgesia. 2007;104:538–540
  21. Nielsen VG, Steenwyk BL, Holman WL, et al. Mechanical circulatory device thrombosis: a new paradigm linking hypercoagulation and hypofibrinolysis. American Society for Artificial Internal Organs Journal. 2008;54:351–358
  22. Mahla E, Lang T, Vicenzi MN, et al. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesthesia and Analgesia. 2001;92:572–577
  23. Gofrit ON, Shapiro A, Rund D, et al. Postoperative thrombocytosis as a marker for complications after urologic surgery. Scandinavian Journal of Urology and Nephrology. 2006;40:161–165
  24. Abrahams JM, Torchia MB, McGarvey M, et al. Perioperative assessment of coagulability in neurosurgical patients using thromboelastography. Surgical Neurology. 2002;58:5–11
  25. O'Donnell J, Riddell A, Owens D, et al. Role of the thrombelastograph as an adjunctive test in thrombophilia screening. Blood Coagulation & Fibrinolysis. 2004;15:207–211
  26. Burke GW, Ciancio G, Figureiro J, et al. Hypercoagulable state associated with kidney-pancreas transplantation. Thromboelastogram-directed anticoagulation and implications for future therapy. Clinical Transplantation. 2004;18:423–428
  27. McCrath DJ, Cerboni E, Frumento RJ, et al. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesthesia and Analgesia. 2005;100:1576–1583
  28. Hvitfeldt Poulsen L, Christiansen K, Sorensen B, Ingerslev J. Whole blood thrombelastographic coagulation profiles using minimal tissue factor activation can display hypercoagulation in thrombosis-prone patients. Scandinavian Journal of Clinical and Laboratory Investigation. 2006;66:329–336
  29. Spiezia L, Marchioro P, Radu C, et al. Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. Blood Coagulation & Fibrinolysis. 2008;19:355–360
  30. Dai Y, Lee A, Critchley LA, White PF. Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature. Anesthesia and Analgesia. 2009;108:734–742
  31. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesthesia and Analgesia. 2008;106:1366–1375
  32. Nielsen VG, Audu P, Cankovic L, et al. Qualitative thrombelastographic method of detection of tissue factor in human plasma. Anesthesia and Analgesia. 2007;104:59–64
  33. Nielsen VG. A comparison of the Thrombelastograph and ROTEM. Blood Coagulation & Fibrinolysis. 2007;18:247–252
  34. Geerts W, Selby R. Prevention of venous thromboembolism in the ICU. Chest. 2003;124:357S–363S
  35. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th Edition). Chest. 2008;133:381S–453S
  36. Strebel N, Prins M, Agnelli G, Buller HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?. Archives of Internal Medicine. 2002;162:1451–1456
  37. Samama CM, Albaladejo P, Benhamou D, et al. Venous thromboembolism prevention in surgery and obstetrics: clinical practice guidelines. European Journal of Anaesthesiology. 2006;23:95–116
  38. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal pelvic surgery. Cochrane Database of Systematic Reviews. 2009;(1):CD004318
  39. Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: american college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:299S–339S
  40. Nutescu EA, Spinler SA, Wittkowsky A, Dager WE. Low-molecular –weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings. The Annals of Pharmacotherapy. 2009;43:1064–1083
  41. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:338S–400S
  42. Hull RD, Pineo GF, Francis C, et al. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators. Archives of Internal Medicine. 2000;160:2199–2207
  43. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a courmarin for the prevention of recurrent venous thromboembolism in patients with cancer. The New England Journal of Medicine. 2003;349:146–153
  44. Ferguson JJ, Califf RM, Antman EM, et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute cornonary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA: The Journal of the American Medical Association. 2004;292:45–54
  45. Rommers MK, Van der Lely N, Egberts TC, van den Bemt PM. Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. Critical Care. 2006;10:R93
  46. Hirsh J. Low molecular weight heparin. 4th edn.. Hamilton, CA: BC Decker; 2007;
  47. Fareed J, Hoppensteadt D, Jeske W, et al. Low molecular weight heparins: a developmental perspective. Expert Opinion on Investigational Drugs. 1997;6(6):705–733

PII: S1521-6896(09)00076-7

doi: 10.1016/j.bpa.2009.09.012

Best Practice & Research Clinical Anaesthesiology
Volume 24, Issue 1 , Pages 133-144 , March 2010

Article Tools

* Image Usage & Resolution